Donald Trump Nominates Former Drug Company Executive as HHS Secretary

Eldonita de Pavel Jacomino
2017-11-17 15:33:11

Pinterest
Telegram
Linkedin
WhatsApp
Alex Azar

Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services.  The post has been vacant since the resignation of Tom Price. 

Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress.  Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”

Rilataj Artikoloj

Komentarioj

Lasu komentarion
Ĉiuj kampoj bezonatas
Ne estos publikigita
captcha challenge
up